ARMISTICE CAPITAL, LLC - 31 Mar 2025 SCHEDULE 13G/A Report for Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share (CYCC)

Filing Manager: ARMISTICE CAPITAL, LLC
Reporting Manager: Armistice Capital, LLC
Security: Cyclacel Pharmaceuticals, Inc. Common Stock, par value $0.001 per share
Symbol: CYCC
Shares outstanding: 270,051,359 shares
Disclosed Ownership: 24,844,725 shares
Ownership: 9.2%
Form type: SCHEDULE 13G/A
Filing time: 15 May 2025, 15:24:28 UTC
Date of event: 31 Mar 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Armistice Capital, LLC	9.2%	24,844,725	0	24,844,725	/s/ Steven Boyd	Steven Boyd - Managing Member
Steven Boyd	9.2%	24,844,725	0	24,844,725	/s/ Steven Boyd	Steven Boyd